Returning to endoscopy normality through the support of a new non-invasive faecal test based on microbial signatures
During the height of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many healthcare facilities needed to focus on screening for and treating patients with known or suspected COVID-19 [1]. This resulted in the diversion of healthcare workers and resources leading to the stop of colorectal cancer (CRC) primary screening and an alarming reduction in endoscopy activity during the COVID-19 pandemic, affecting and changing the daily practice of gastrointestinal endoscopy (both diagnostic and therapeutic) and will do so for the foreseeable future.
Source: Digestive and Liver Disease - Category: Gastroenterology Authors: M. Malag ón, L. Oliver, S. Ramió-Pujol, J. Guardiola, F. Balaguer Tags: Correspondence Source Type: research
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Coronavirus | COVID-19 | Endoscopy | Gastroenterology | Liver | Liver Disease | Pandemics | Respiratory Medicine | SARS | Urology & Nephrology